Esperer Onco appoints Dr Vivek Srivastav as VP-R&D operations and Dr Anubhab Mukherjee as principal scientist, R&D division

Our Bureau, BengaluruThursday, August 27, 2020, 12:40 Hrs  [IST]

Esperer Onco Nutrition (EON) has now appointed to senior officials to strengthen its lead cancer research in the country. Joining the organization are Dr Vivek Srivastav and Dr Anubhab Mukherjee. While Dr Srivastav will serve as the vice-president, R&D and operations, Dr Mukherjee will be serving as principal scientist, research and development division. “We at Esperer are glad to welcome resourceful intelligentsia in our crucial research and development department. I am sure both Dr Srivastav and Dr Mukherjee will foster and hone the best research practices and help Esperer Onco Nutrition to develop better mediums to offer nutrition at all stages of the critical disease management focussed on cancer,” said Raktim Chattopadhyay, founder & CEO at Esperer Onco Nutrition. Prior to joining EON, Dr. Srivastav was the director-research & development (Enteral Nutrition), North-East South-East Asia (NESEA), Member of Leadership Team at Fresenius Kabi India Pvt. Ltd. With his strong research experience, Dr Vivek carries MD with PhD in phyto nutrients as education. He promises to add value to the mission of EON as a research organization. Dr Mukherjee joins as a principal scientist, R&D in Esperer Onco Nutrition (EON) Pvt. Ltd and heads the Hyderabad R&D center for the organization as well. He has a Ph.D. from CSIR-Indian Institute of Chemical Technology, India. He has in-depth experience in the cancer & nanomedicine space and has been a part of two post-doctoral research in the US. At EON he plans to spearhead the quest for ultimate nutritional care through different delivery mechanisms for cancer patients.